Hosted on MSN26d
AbbVie gets FDA approval for antibiotic treatment Emblaveo (update)
AbbVie (NYSE:ABBV) said it has received FDA approval for the intravenous antibiotic treatment Emblaveo, which was co-developed with Pfizer (NYSE:PFE). The FDA approved Emblaveo, a combination of ...
Hosted on MSN1mon
FDA approves novel antibiotic EMBLAVEO for cIAI
N ORTH CHICAGO, Ill. - The U.S. Food and Drug Administration (FDA) has approved EMBLAVEO™ (aztreonam and avibactam) for the treatment of adults with complicated intra-abdominal infections (cIAI ...
clinicaladvisor.com1mon
Emblaveo Approved for Intra-Abdominal Infections in Patients With Limited Options
Approval of this indication is based on limited clinical safety and efficacy data for Emblaveo. In REVISIT, study participants with cIAI (n=312) were randomly assigned 2:1 to receive aztreonam ...
Crain's Chicago Business1mon
AbbVie gets FDA OK on antibiotic therapy that fights resistant bacteria
AbbVie's combination antibiotic Emblaveo has gotten federal approval to treat complicated intra-abdominal infections, making it the first and only such therapy approved to fight antimicrobial ...
Renal & Urology News29d
Emblaveo Approved for Intra-Abdominal Infections in Patients With Limited Options
The Food and Drug Administration (FDA) has approved Emblaveo™ (aztreonam and avibactam), in combination with metronidazole, for patients 18 years and older who have limited or no alternative ...